Arkolith/Insider Trading/TCRR/Form 4

Harrison Rosemary

Chief Business & StrategyTCR2 THERAPEUTICS INC. (TCRR) · full profile →Form 4 · filed Dec 19, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2022Grant(A)13K—$013K
Dec 15, 2022Grant(A)77K—$077K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-039012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML